Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gut-Brain Axis01:22

Gut-Brain Axis

11
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
11
Functions of the Gut Microbiota01:18

Functions of the Gut Microbiota

1
The gut microbiota includes trillions of microorganisms that colonize the human gastrointestinal tract, including bacteria, archaea, viruses, and fungi. This complex ecosystem plays a critical role in maintaining intestinal and systemic health. Most of these microbes inhabit the large intestine, establishing a relatively stable and diverse community that contributes to gut homeostasis through various metabolic, immunological, and protective mechanisms.Dominant bacterial phyla, such as...
1
Microbiota of the Large Intestine01:27

Microbiota of the Large Intestine

1
The large intestine hosts the most densely populated microbial ecosystem in the human body. This complex community primarily consists of anaerobic bacteria, with Bacillota (formerly Firmicutes) and Bacteroidota (formerly Bacteroidetes) as the predominant groups. The distribution of these microbes varies along different sections of the large intestine, influenced by local environmental factors such as oxygen availability and nutrient composition.The cecum, located at the beginning of the large...
1
Introduction to the Human Microbiota01:22

Introduction to the Human Microbiota

22
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity,...
22
The Oral Microbiota01:27

The Oral Microbiota

7
The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
7
Development of Human Microbiota01:30

Development of Human Microbiota

5
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
5

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expert perspectives on Myalgic encephalomyelitis/chronic fatigue syndrome - Insights from the 3<sup>rd</sup> International Conference of the Charité Fatigue Center.

Autoimmunity reviews·2026
Same author

Spacing of a TNF inhibitor or dose reduction of methotrexate vs continued treatment in patients with rheumatoid arthritis in remission or low disease activity: a randomised, controlled trial (SORAIRO trial).

Annals of the rheumatic diseases·2026
Same author

A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.

Multiple sclerosis and related disorders·2026
Same author

Eomesodermin-expressing CD4 Th cells and association with multiple sclerosis progression and brain atrophy.

Brain communications·2025
Same author

Long-Term Efficacy and Safety of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disorder From the SAkuraMoon Open-Label Extension Study.

Neurology(R) neuroimmunology & neuroinflammation·2025
Same author

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance.

Neurology and therapy·2025

Related Experiment Video

Updated: Mar 19, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.5K

[Multiple Sclerosis and Commensal Gut Flora].

Takashi Yamamura1

  • 1Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|June 10, 2016
PubMed
Summary
This summary is machine-generated.

Gut microbiota, crucial for host health, may influence multiple sclerosis (MS) development. Reduced clostridia strains in MS patients suggest a link between gut dysbiosis and the disease, impacting immune regulation.

More Related Videos

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.7K
Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
09:49

Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection

Published on: November 18, 2022

2.9K

Related Experiment Videos

Last Updated: Mar 19, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
11:22

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing

Published on: October 15, 2019

31.5K
Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
08:24

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

20.7K
Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection
09:49

Investigation of Microbial Cooperation via Imaging Mass Spectrometry Analysis of Bacterial Colonies Grown on Agar and in Tissue During Infection

Published on: November 18, 2022

2.9K

Area of Science:

  • Microbiology and Immunology
  • Neuroscience
  • Gastroenterology

Background:

  • The gut microbiota's role has shifted from symbiosis to mutualism, protecting against inflammatory bowel diseases and obesity.
  • Gut dysbiosis is implicated in the development of various host disorders.
  • Experimental autoimmune encephalomyelitis (EAE), a model for multiple sclerosis (MS), suggests gut microbiota dysbiosis can trigger MS onset.

Purpose of the Study:

  • To investigate the potential link between gut microbiota composition and multiple sclerosis (MS).
  • To identify specific microbial changes associated with MS in patients.
  • To explore the role of gut bacteria in immune regulation relevant to MS pathogenesis.

Main Methods:

  • Analysis of gut microbiota composition in patients with multiple sclerosis (MS).
  • Comparison of microbial profiles between MS patients and healthy controls (implied).
  • Focus on specific bacterial strains, particularly Clostridia, and their potential immune functions.

Main Results:

  • A significant reduction in specific Clostridia strains was observed in the gut microbiota of MS patients.
  • These identified Clostridia strains are hypothesized to play a role in inducing regulatory T cells.
  • This finding suggests a potential mechanism linking gut dysbiosis to MS pathogenesis via immune dysregulation.

Conclusions:

  • Gut microbiota dysbiosis, specifically a reduction in certain Clostridia, may be associated with multiple sclerosis (MS).
  • The identified Clostridia strains' role in regulatory T cell induction highlights a potential pathway for MS development.
  • These results have implications for developing novel prevention and treatment strategies for MS targeting the gut microbiome.